Omada Health, Inc.
OMDA
$18.32
$0.442.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.90% | 11.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.90% | 11.49% | |||
| Cost of Revenue | 32.33% | -3.38% | |||
| Gross Profit | -9.26% | 19.06% | |||
| SG&A Expenses | 5.02% | 4.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.14% | 2.87% | |||
| Operating Income | -245.72% | 230.56% | |||
| Income Before Tax | -157.57% | 262.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -157.57% | 262.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -157.57% | 262.33% | |||
| EBIT | -245.72% | 230.56% | |||
| EBITDA | -169.23% | 509.71% | |||
| EPS Basic | -156.69% | 261.34% | |||
| Normalized Basic EPS | -156.76% | 578.45% | |||
| EPS Diluted | -162.45% | 246.46% | |||
| Normalized Diluted EPS | -162.50% | 534.48% | |||
| Average Basic Shares Outstanding | 1.49% | 0.69% | |||
| Average Diluted Shares Outstanding | -7.83% | 10.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||